National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
NCT04604990
Summary
SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.
Eligibility
Inclusion Criteria: 1. Adult patients defined as age greater than 18 years old. 2. Patients should fulfil one of the following classification criteria for SLE (ACR, SLICC or ACR/EULAR criteria). 3. No restriction on time of diagnosis. Exclusion Criteria: * Patients who don't fulfil classification criteria mentioned above.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT04604990